To see, or not to see, that is the question: can public disclosure really improve transparency between medicine and the pharmaceutical industry?

Abstract

OBJECTIVE To critically review the potential effect of the public reporting of pharmaceutical company payments to healthcare professionals on the relationship between medicine and industry. METHOD This review is based on an examination of the 'Transparency Model' put out recently for consultation by Medicines Australia. RESULTS Public reporting in… (More)

Topics

Cite this paper

@article{Smith2014ToSO, title={To see, or not to see, that is the question: can public disclosure really improve transparency between medicine and the pharmaceutical industry?}, author={Geoffrey P S Smith}, journal={Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists}, year={2014}, volume={22 3}, pages={281-284} }